BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33353724)

  • 1. Imaging of Tau Pathology in Neurodegenerative Diseases: An Update.
    Beyer L; Brendel M
    Semin Nucl Med; 2021 May; 51(3):253-263. PubMed ID: 33353724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains.
    Lemoine L; Gillberg PG; Svedberg M; Stepanov V; Jia Z; Huang J; Nag S; Tian H; Ghetti B; Okamura N; Higuchi M; Halldin C; Nordberg A
    Alzheimers Res Ther; 2017 Dec; 9(1):96. PubMed ID: 29229003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau PET imaging in neurodegenerative tauopathies-still a challenge.
    Leuzy A; Chiotis K; Lemoine L; Gillberg PG; Almkvist O; Rodriguez-Vieitez E; Nordberg A
    Mol Psychiatry; 2019 Aug; 24(8):1112-1134. PubMed ID: 30635637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical Characterization of the Tau PET Tracer [
    Harada R; Lerdsirisuk P; Shimizu Y; Yokoyama Y; Du Y; Kudo K; Ezura M; Ishikawa Y; Iwata R; Shidahara M; Ishiki A; Kikuchi A; Hatano Y; Ishihara T; Onodera O; Iwasaki Y; Yoshida M; Taki Y; Arai H; Kudo Y; Yanai K; Furumoto S; Okamura N
    J Nucl Med; 2023 Sep; 64(9):1495-1501. PubMed ID: 37321821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head-to-head comparison of [
    Aguero C; Dhaynaut M; Amaral AC; Moon SH; Neelamegam R; Scapellato M; Carazo-Casas C; Kumar S; El Fakhri G; Johnson K; Frosch MP; Normandin MD; Gómez-Isla T
    Acta Neuropathol; 2024 Jan; 147(1):25. PubMed ID: 38280071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau PET Imaging in Neurodegenerative Disorders.
    Groot C; Villeneuve S; Smith R; Hansson O; Ossenkoppele R
    J Nucl Med; 2022 Jun; 63(Suppl 1):20S-26S. PubMed ID: 35649647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.
    Leuzy A; Smith R; Ossenkoppele R; Santillo A; Borroni E; Klein G; Ohlsson T; Jögi J; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Stomrud E; Hansson O
    JAMA Neurol; 2020 Aug; 77(8):955-965. PubMed ID: 32391858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual tracer tau PET imaging reveals different molecular targets for
    Chiotis K; Stenkrona P; Almkvist O; Stepanov V; Ferreira D; Arakawa R; Takano A; Westman E; Varrone A; Okamura N; Shimada H; Higuchi M; Halldin C; Nordberg A
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1605-1617. PubMed ID: 29752516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau Imaging in Neurodegenerative Diseases Using Positron Emission Tomography.
    Wang YT; Edison P
    Curr Neurol Neurosci Rep; 2019 Jun; 19(7):45. PubMed ID: 31172290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-interaction of tau PET tracers with monoamine oxidase B: evidence from in silico modelling and in vivo imaging.
    Murugan NA; Chiotis K; Rodriguez-Vieitez E; Lemoine L; Ågren H; Nordberg A
    Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1369-1382. PubMed ID: 30919054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head to head comparison of [
    Jang YK; Lyoo CH; Park S; Oh SJ; Cho H; Oh M; Ryu YH; Choi JY; Rabinovici GD; Kim HJ; Moon SH; Jang H; Lee JS; Jagust WJ; Na DL; Kim JS; Seo SW
    Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):432-442. PubMed ID: 29143870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptic Sites in Tau Fibrils Explain the Preferential Binding of the AV-1451 PET Tracer toward Alzheimer's Tauopathy.
    Murugan NA; Nordberg A; Ågren H
    ACS Chem Neurosci; 2021 Jul; 12(13):2437-2447. PubMed ID: 34152739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of 3 Novel Tau Radiopharmaceuticals,
    Wong DF; Comley RA; Kuwabara H; Rosenberg PB; Resnick SM; Ostrowitzki S; Vozzi C; Boess F; Oh E; Lyketsos CG; Honer M; Gobbi L; Klein G; George N; Gapasin L; Kitzmiller K; Roberts J; Sevigny J; Nandi A; Brasic J; Mishra C; Thambisetty M; Mogekar A; Mathur A; Albert M; Dannals RF; Borroni E
    J Nucl Med; 2018 Dec; 59(12):1869-1876. PubMed ID: 29728519
    [No Abstract]   [Full Text] [Related]  

  • 14. 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease.
    Harada R; Okamura N; Furumoto S; Furukawa K; Ishiki A; Tomita N; Tago T; Hiraoka K; Watanuki S; Shidahara M; Miyake M; Ishikawa Y; Matsuda R; Inami A; Yoshikawa T; Funaki Y; Iwata R; Tashiro M; Yanai K; Arai H; Kudo Y
    J Nucl Med; 2016 Feb; 57(2):208-14. PubMed ID: 26541774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large inter- and intra-case variability of first generation tau PET ligand binding in neurodegenerative dementias.
    Wren MC; Lashley T; Årstad E; Sander K
    Acta Neuropathol Commun; 2018 May; 6(1):34. PubMed ID: 29716656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Evaluation of 18F-PI-2620 as a Potent PET Radiotracer Imaging Tau Protein in Alzheimer Disease and Other Neurodegenerative Diseases Compared With 18F-THK-5351.
    Oh M; Oh SJ; Lee SJ; Oh JS; Roh JH; Chung SJ; Lee JH; Lee CS; Kim JS
    Clin Nucl Med; 2020 Nov; 45(11):841-847. PubMed ID: 32910050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classics in Neuroimaging: Untangling the Role of Tau in Neurodegenerative Disorders Using Positron Emission Tomography.
    Witek JA; Brooks AF; Scott PJH
    ACS Chem Neurosci; 2022 Oct; 13(19):2778-2783. PubMed ID: 36112411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau imaging in neurodegenerative diseases.
    Dani M; Brooks DJ; Edison P
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1139-50. PubMed ID: 26572762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease.
    Okamura N; Furumoto S; Harada R; Tago T; Yoshikawa T; Fodero-Tavoletti M; Mulligan RS; Villemagne VL; Akatsu H; Yamamoto T; Arai H; Iwata R; Yanai K; Kudo Y
    J Nucl Med; 2013 Aug; 54(8):1420-7. PubMed ID: 23857514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue.
    Aguero C; Dhaynaut M; Normandin MD; Amaral AC; Guehl NJ; Neelamegam R; Marquie M; Johnson KA; El Fakhri G; Frosch MP; Gomez-Isla T
    Acta Neuropathol Commun; 2019 Mar; 7(1):37. PubMed ID: 30857558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.